Literature DB >> 306592

Lymphocyte mediated natural cytotoxicity in neoplasia.

M Menon, S S Stefani.   

Abstract

Peripheral blood lymphoid cells from normal donors, patients with non-malignant diseases, and patients with malignant diseases were evaluated for cytotoxicity against a cultured carcinoma cell line, using a chromium release assay. The natural spontaneous lymphocyte-mediated cytotoxicity was significantly higher in tumor-free groups. The observed decreased response in patients with malignancies correlated with depressed responsiveness to phytohemagglutinin stimulation. Removal of cell subpopulations bearing Fc receptors significantly decreased the cytotoxicity, while depletion of phagocytic mononuclear cells did not. We suggest that natural cytotoxicity is a measure of cell membrane integrity of lymphocytes and should be included as a routine test for evaluation of general immune competence.

Entities:  

Mesh:

Year:  1978        PMID: 306592     DOI: 10.1159/000225257

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  7 in total

1.  Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.

Authors:  N Saijo; E Shimizu; N Irimajiri; A Ozaki; K Kimura; T Takizawa; H Niitani
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

2.  Natural cell-mediated cytotoxicity in normal human peripheral blood lymphocytes and its in vitro boosting with BCG.

Authors:  R Mandeville; F M Sombo; N Rocheleau
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity.

Authors:  H F Pross; M G Baines; P Rubin; P Shragge; M S Patterson
Journal:  J Clin Immunol       Date:  1981-01       Impact factor: 8.317

4.  Enhanced K-cell activity in the peripheral blood of patients with malignant disease.

Authors:  T Bakács; P Czanik; I Kimber; G Ringwald; M Moore; E Abrahám
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease.

Authors:  D White; D B Jones; T Cooke; N Kirkham
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

6.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

7.  Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung.

Authors:  N Saijo; E Shimizu; M Shibuya; N Irimajiri; T Takizawa; K Eguchi; T Shinkai; K Tominaga; Z Shimabukuro; T Taniguchi; A Hoshi
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.